View Older Stories
-
West Pharmaceutical (WST) PT Raised to $365 at TD Cowen
-
West Pharmaceutical (WST) PT Raised to $390 at Evercore ISI
-
West Pharma (WST) Tops Q1 EPS by 45c, provides guidance
-
TD Cowen Reiterates Top Pick on Halozyme Therapeutics (HALO)
-
West Pharma (WST) 3300 contracts of May 210 puts trade
-
West Pharma (WST) Tops Q4 EPS by 20c, provides guidance
-
West Pharmaceutical launches Synchrony S1 prefillable syringe system
-
Halozyme Therapeutics (HALO) PT Raised at TD Cowen; 'One of Our Top Picks for 2026'
-
Nephron Upgrades West Pharmaceutical (WST) to Buy
-
KeyBanc on Life Sciences Tools & Services: 'We Highlight Our Favored 2026 "Tools" Stocks'
-
Morgan Stanley Starts West Pharmaceutical (WST) at Equalweight, 'Valuation Rich'
-
KeyBanc: White House GLP-1 Deals Boost Growth Potential for Key Suppliers
-
TD Cowen Starts West Pharmaceutical (WST) at Buy
-
Evercore ISI Removes West Pharmaceutical (WST) from Tactical Outperform List
-
West Pharmaceutical (WST) PT Raised to $350 at KeyBanc on 'Improving Visibility'
-
West Pharmaceutical (WST) PT Raised to $370 at BofA Securities
-
West Pharmaceutical (WST) PT Raised to $390 at Evercore ISI
-
West Pharma (WST) Tops Q3 EPS by 27c; raises guidance
-
Evercore Adds Names to TAP Lists
-
KeyBanc Takeaways from This Year's BioProcess International Conference
-
Rothschild Redburn Starts West Pharmaceutical (WST) at Buy
-
KeyBanc Reiterates Overweight Rating on West Pharmaceutical (WST)
-
West Pharma (WST) call put ratio 2.8 calls to 1 put with a focus on December calls as share price up 20%
-
West Pharmaceutical (WST) PT Raised to $350 at Evercore ISI
-
West Pharma (WST) Declares $0.22 Quarterly Dividend; 0.4% Yield
-
West Pharma (WST) Tops Q2 EPS by 33c, provides guidance
-
WST DEADLINE: ROSEN, A LEADING AND RANKED FIRM, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 7 Deadline in Securities
-
Faruqi & Faruqi Reminds West Pharmaceuticals Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST
-
WST DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 7 Deadline in Securities Clas
-
WST Investors Have the Opportunity to Lead the West Pharmaceutical Services Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
-
WST DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 7 Deadline in Securities Class A
-
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services
-
WST IMPORTANT DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 7 Deadline in Sec
-
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services
-
WST IMPORTANT DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 7 Deadline i
-
WST FINAL DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 7 Deadline in Securit
-
WST DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important July 7 Deadline in Securities Cl
-
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services
-
WST FINAL DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important July 7 Deadline in Securities Class Action - WST
-
Kuehn Law Encourages Investors of West Pharmaceutical Services, Inc. to Contact Law Firm
-
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
Barclays Starts West Pharmaceutical (WST) at Equalweight
-
WST FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important July 7 Deadline in Securities Class Action - WST
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services
-
WST DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WST
-
WST Investors Have the Opportunity to Lead the West Pharmaceutical Services Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
-
WST DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WST
-
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services
-
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

